A share price of Johnson & Johnson [JNJ] is currently trading at $154.69, down -0.47%. An important factor to consider is whether the stock is rising or falling in short-term value. The JNJ shares have gain 3.21% over the last week, with a monthly amount glided 6.21%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, HSBC Securities upgraded its rating to Buy on April 18, 2024, and kept the price target unchanged to $170. On December 13, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $163 on the stock. UBS upgraded its rating to a Buy and increased its price target to $180 on December 01, 2023. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $178 as its price target on October 05, 2023. HSBC Securities started tracking with a Hold rating for this stock on September 06, 2023, and assigned it a price target of $175.
Johnson & Johnson experienced fluctuations in its stock price throughout the past year between $143.13 and $175.97. Currently, Wall Street analysts expect the stock to reach $177 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $154.69 at the most recent close of the market. An investor can expect a potential return of 14.42% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
Trailing Twelve Months sales for Johnson & Johnson [NYSE:JNJ] were 86.56B which represents -12.13% decline. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.44%. To continue investigating profitability, this company’s Return on Assets is posted at 0.22, Equity is 0.53 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.48.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 153.70 points at the first support level, and at 152.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 156.09, and for the 2nd resistance point, it is at 157.50.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Johnson & Johnson [NYSE:JNJ] is 1.17. On the other hand, the Quick Ratio is 0.94, and the Cash Ratio is 0.52. Considering the valuation of this stock, the price to sales ratio is 4.30, the price to book ratio is 5.32 and price to earnings (TTM) ratio is 22.36.
Transactions by insiders
Recent insider trading involved Broadhurst Vanessa, EVP, Global Corp Affairs, that happened on Mar 13 ’24 when 8891.0 shares were sold. 10% Owner, JOHNSON & JOHNSON completed a deal on Feb 16 ’24 to sell 3725.0 shares. Meanwhile, EVP, WW Chair, Pharmaceuticals Taubert Jennifer L sold 59397.0 shares on Feb 09 ’24.
